Thomas Kassberg
2016
In 2016, Thomas Kassberg earned a total compensation of $1.9M as Chief Business Officers and Executive Vice President at Ultragenyx Pharmaceutical, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,296 |
|---|---|
| Option Awards | $1,025,693 |
| Salary | $405,600 |
| Stock Awards | $282,280 |
| Other | $35,561 |
| Total | $1,915,430 |
Kassberg received $1M in option awards, accounting for 54% of the total pay in 2016.
Kassberg also received $166.3K in non-equity incentive plan, $405.6K in salary, $282.3K in stock awards and $35.6K in other compensation.
Rankings
In 2016, Thomas Kassberg's compensation ranked 5,079th out of 14,075 executives tracked by ExecPay. In other words, Kassberg earned more than 63.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,079 out of 14,075 | 64th |
Division Manufacturing | 1,812 out of 5,489 | 67th |
Major group Chemicals And Allied Products | 575 out of 1,895 | 70th |
Industry group Drugs | 431 out of 1,538 | 72nd |
Industry Pharmaceutical Preparations | 345 out of 1,176 | 71st |
Source: SEC filing on April 27, 2018.
Kassberg's colleagues
We found five more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2016.
2016
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2016
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2016
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2016
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2016
Shalini Sharp
Ultragenyx Pharmaceutical